Patent foramen ovale: Standards for a preclinical model of prevalence, structure, and histopathologic comparability to human hearts

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 2, 2007, Pages 266-273

  Hara, Hidehiko ^a   Virmani, Renu ^b   Ladich, Elena ^b   Mackey Bojack, Shannon ^c   Titus, Jack L ^c   Karnicki, Krzysztov ^d   Stewart, Marylou ^d   Pelzel, Jamie M ^a   Schwartz, Robert S ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b CVPATH INSTITUTE   (United States)

^c Nasseff Heart Center   (United States)

^d Medical Laboratory Surgical Services   (United States)

Author keywords

Animal model; Atrial shunt; Patent foramen ovale

Indexed keywords

ANIMAL TISSUE; ARTICLE; DISEASE MODEL; HEART ATRIUM SEPTUM DEFECT; HEART SIZE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PATHOLOGICAL ANATOMY; PREVALENCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SWINE;

ADOLESCENT; ADULT; ANIMALS; CADAVER; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; LINEAR MODELS; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; RETROSPECTIVE STUDIES; SWINE;

EID: 33846794610     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20973     Document Type: Article

References (18)

1. Hara H, Virmani R, Ladich E, et al. Patent foramen ovale: Current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 2005;46:1768-1776.
2. Topaz O, Edwards JE, Bojack-Mackey S, Titus JL. Aneurysm of fossa ovalis in adults: A pathologic study. Cardiovasc Pathol 2003;12:219-225.
3. Skowasch M. Revolutionary non-implant closure system for patent foramen ovale: First in human results. Circulation 2005;112(Suppl II):649.
4. Schwartz RS, Edelman ER, Carter A, et al. Drug-eluting stents in preclinical studies: Recommended evaluation from a consensus group. Circulation 2002;106:1867-1873.
5. Schwartz RS, Edelman ER, Carter A, et al. Preclinical evaluation of drug-eluting stents for peripheral applications: Recommendations from an expert consensus group. Circulation 2004;110:2498-2505.
6. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: Still important, still much to learn. J Am Coll Cardiol 2004;44:1373-1385.
7. Cohnheim J. A general pathologic lecture. Thrombosis and Embolism; William Henry Welsh 1899. pp 134-137.
8. Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, Khandheria BK. Patent foramen ovale in cryptogenic stroke: Current understanding and management options. Arch Intern Med 2004;164:950-956.
9. Cheng TO. Platypnea-orthodeoxia syndrome: Etiology, differential diagnosis, and management. Catheter Cardiovasc Interv 1999;47:64-66.
10. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998;97:1946-1951.
11. Cartoni D, De Castro S, Valente G, Costanzo C, Pelliccia A, Beni S, Di Angelantonio E, Papetti F, Vitali Serdoz L, Fedele F. Identification of professional scuba divers with patent foramen ovale at risk for decompression illness. Am J Cardiol 2004;94:270-273.
12. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-495.
13. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: Impact of transcatheter closure. J Am Coll Cardiol 2005;45:489-492.
14. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
15. Anzai H, Child J, Natterson B, Krivokapich J, Fishbein MC, Chan VK, Tobis JM. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol 2004;93:426-431.
16. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
17. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003;139:753-760.
18. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.